The global Psoriasis Treatment Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Psoriasis Treatment Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Psoriasis Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Segment by Type
TNF Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Corticosteroids
Others
Segment by Application
Oral
Parenteral
Topical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Psoriasis Treatment Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 TNF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 Vitamin D Analogs
1.2.5 Corticosteroids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Psoriasis Treatment Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Treatment Drugs Market Perspective (2018-2029)
2.2 Psoriasis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriasis Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2024-2029)
2.3 Psoriasis Treatment Drugs Market Dynamics
2.3.1 Psoriasis Treatment Drugs Industry Trends
2.3.2 Psoriasis Treatment Drugs Market Drivers
2.3.3 Psoriasis Treatment Drugs Market Challenges
2.3.4 Psoriasis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2018-2023)
3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Treatment Drugs Revenue
3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2022
3.5 Psoriasis Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Psoriasis Treatment Drugs Product Solution and Service
3.7 Date of Enter into Psoriasis Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2024-2029)
5 Psoriasis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Psoriasis Treatment Drugs Market Size (2018-2029)
6.2 North America Psoriasis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Psoriasis Treatment Drugs Market Size by Country (2018-2023)
6.4 North America Psoriasis Treatment Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriasis Treatment Drugs Market Size (2018-2029)
7.2 Europe Psoriasis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2018-2023)
7.4 Europe Psoriasis Treatment Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2018-2029)
8.2 Asia-Pacific Psoriasis Treatment Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriasis Treatment Drugs Market Size (2018-2029)
9.2 Latin America Psoriasis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2018-2023)
9.4 Latin America Psoriasis Treatment Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2018-2029)
10.2 Middle East & Africa Psoriasis Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Psoriasis Treatment Drugs Introduction
11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Psoriasis Treatment Drugs Introduction
11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Dermira
11.3.1 Dermira Company Detail
11.3.2 Dermira Business Overview
11.3.3 Dermira Psoriasis Treatment Drugs Introduction
11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.3.5 Dermira Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Psoriasis Treatment Drugs Introduction
11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Psoriasis Treatment Drugs Introduction
11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.9.5 AstraZeneca Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.10.5 AbbVie Recent Development
11.11 LEO Pharma
11.11.1 LEO Pharma Company Detail
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.11.5 LEO Pharma Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Psoriasis Treatment Drugs Introduction
11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.12.5 Biogen Recent Development
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Company Detail
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.13.5 Galectin Therapeutics Recent Development
11.14 Cellceutix
11.14.1 Cellceutix Company Detail
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.14.5 Cellceutix Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Psoriasis Treatment Drugs Introduction
11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2018-2023)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
*If Applicable.